In the BioHarmony Drug Report Database
Probucol
Lorelco (probucol) is a small molecule pharmaceutical. Probucol was first approved as Lorelco on 1982-01-01. It is used to treat coronary artery disease, hypercholesterolemia, and hyperlipoproteinemias in the USA. The pharmaceutical is active against phospholipid-transporting ATPase ABCA1.
Trade Name
|
Lorelco |
|---|---|
Common Name
|
probucol |
ChEMBL ID
|
CHEMBL608 |
Indication
|
coronary artery disease, hypercholesterolemia, hyperlipoproteinemias |
Drug Class
|
Image (chem structure or protein)